Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Instituto de Investigaciones Biomédicas Alberto Sols](/img/noimage_org.png)
Instituto de Investigaciones Biomédicas Alberto Sols
Madrid, EspañaInstituto de Investigaciones Biomédicas Alberto Sols-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2018
-
GQ-11: A new PPAR agonist improves obesity-induced metabolic alterations in LDLr-/- mice
International Journal of Obesity, Vol. 42, Núm. 5, pp. 1062-1072
2016
-
New PPARγ partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr
-/-
mice
Pharmacological Research, Vol. 104, pp. 49-60
2015
-
A labdane diterpene exerts ex vivo and in vivo cardioprotection against post-ischemic injury: Involvement of AKT-dependent mechanisms
Biochemical Pharmacology, Vol. 93, Núm. 4, pp. 428-439
-
New indole-thiazolidine attenuates atherosclerosis in LDLr-/- mice
Vascular Pharmacology, Vol. 71, pp. 174-180
-
α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation
Toxicology and Applied Pharmacology, Vol. 286, Núm. 3, pp. 168-177
2013
-
Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives
Oncogene, Vol. 32, Núm. 2, pp. 259-268
2010
-
Electronegative LDL induction of apoptosis in macrophages: Involvement of Nrf2
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1801, Núm. 4, pp. 430-437
2008
-
Supression of inflammatory responses by labdane-type diterpenoids
Toxicology and Applied Pharmacology, Vol. 228, Núm. 2, pp. 179-189
2007
-
Kaurane diterpenes protect against apoptosis and inhibition of phagocytosis in activated macrophages
British Journal of Pharmacology, Vol. 152, Núm. 2, pp. 249-255